The Open UniversitySkip to content
 

Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher’s disease

Rasmussen, Tina S.; Allman, Sarah; Twigg, Gabriele; Butters, Terry D. and Jensen, Henrik H. (2011). Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher’s disease. Bioorganic & Medicinal Chemistry Letters, 21(5) pp. 1519–1522.

DOI (Digital Object Identifier) Link: https://doi.org/10.1016/j.bmcl.2010.12.106
Google Scholar: Look up in Google Scholar

Abstract

The potent and selective inhibitor of β-glucosidases, noeurostegine, was evaluated as an inhibitor of glucocerebrosidase (GCase) to give an IC50 value of 0.4 μM, being 250- and 150-fold better than N-butyl and N-nonyl noeurostegine, respectively. The parent noeurostegine and its N-butyl and N-nonyl alkylated congeners were also tested as pharmacological chaperones against a N370S GCase mutant. Of these, only noeurostegine, was found to increase enzyme activity, which in potency was comparable to that previously reported for isofagomine.

Item Type: Journal Item
Copyright Holders: 2011 Elsevier Ltd.
ISSN: 1464-3405
Keywords: nortropane; inhibition; glucocerebrosidase; chaperone
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Item ID: 38119
Depositing User: Sarah Allman
Date Deposited: 08 Aug 2013 08:18
Last Modified: 07 Dec 2018 10:17
URI: http://oro.open.ac.uk/id/eprint/38119
Share this page:

Metrics

Altmetrics from Altmetric

Citations from Dimensions

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU